This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
RDN Stock Trading at Discount to Industry at 1.02X: Time to Buy?
by Zacks Equity Research
Radian Group stock rallies on the back of an improving mortgage insurance portfolio, declining claims, a solid capital position and effective capital deployment.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), EMCOR Group (EME) and Sprouts Farmers Market (SFM).
Wall Street Analysts See a 78.13% Upside in EverQuote (EVER): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for EverQuote (EVER) points to a 78.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ROOT Stock Skyrockets 627% YTD: Time to Buy Despite Premium Valuation?
by Tanuka De
Despite its expensive valuation, given its focus on driving growth, its price appreciation and its VGM Score of B, you can bet on ROOT stock.
ORI Stock Trading at Discount to Industry at 1.43X: Time to Hold?
by Zacks Equity Research
Old Republic rides on high renewal retention ratios, well-performing Title business, financial flexibility, favorable growth estimates and higher return on capital.
EVER Rallies 51.2% YTD: Time to Add the Stock for Better Returns?
by Zacks Equity Research
EverQuote stock gains from higher quote request volume, solid performance of automotive and other insurance marketplace verticals and favorable growth estimates.
BRO Rallies 53.6% YTD: Time to Buy the Stock for Solid Returns?
by Zacks Equity Research
Brown & Brown remains well-poised for growth on higher core commissions and fees, new business, solid retention, strategic acquisitions and effective capital deployment.
AJG Rallies 35% YTD but Lags Industry: How to Play the Stock
by Zacks Equity Research
Arthur J. Gallagher gains on the back of solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is EverQuote (EVER) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UNM Stock Gains 68.9% YTD: What Should Be Investors' Approach Now?
by Zacks Equity Research
Unum Group stock rallies on favorable benefits experience, higher sales, strong persistency, improved premium income and prudent capital deployment.
Assurant Stock Gains 34% YTD: What Should Be Investors' Approach Now?
by Zacks Equity Research
AIZ stock gains on the back of a well-performing Global Lifestyle business, growth of fee-based capital-light businesses and effective capital deployment.
Bet on Winning DuPont Analysis & Pick 4 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Expeditors International of Washington (EXPD), EMCOR Group (EME), and Sprouts Farmers Market (SFM).
Wall Street Analysts Think EverQuote (EVER) Could Surge 67.9%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for EverQuote (EVER) points to a 67.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
MGIC Investment Stock Rises 35.3% YTD: More Room for Growth?
by Zacks Equity Research
MTG stock rallies on the back of solid insurance in force, lower delinquency, better housing market fundamentals and solid growth projections.
Earnings Estimates Moving Higher for EverQuote (EVER): Time to Buy?
by Zacks Equity Research
EverQuote (EVER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Radian Group Stock Rises 32.9% in a Year: More Room for Growth?
by Zacks Equity Research
RDN stock rallies on the back of an improving mortgage insurance portfolio, declining claims, a solid capital position and effective capital deployment.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks.com featured highlights include Casey's, EMCOR, EverQuote and Sprouts Farmers Market
by Zacks Equity Research
Casey's, EMCOR, EverQuote and Sprouts Farmers Market have been highlighted in this Screen of The Week article.
Do Options Traders Know Something About EverQuote (EVER) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to EverQuote (EVER) stock based on the movements in the options market lately.
Radian Group Q3 Earnings Beat Estimates on Higher Revenues
by Zacks Equity Research
RDN's Q3 results reflect solid performance in the All Other segment and higher primary mortgage insurance in force, partially offset by higher expenses.
EverQuote Q3 Earnings, Revenues Top on Strong Automotive Vertical
by Zacks Equity Research
EVER's Q3 results reflect solid performances across Automotive insurance and Home and Renters insurance verticals, partially offset by higher expenses.
EverQuote (EVER) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for EverQuote (EVER) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EverQuote (EVER) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 63.16% and 2.94%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?